Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06)

Younghee Park,Young Seob Shin,Kyubo Kim,Kyung Hwan Shin,Ji Hyun Chang,Su Ssan Kim,Jin Hong Jung,Won Park,Haeyoung Kim,Yong Bae Kim,Sung Ja Ahn,Myungsoo Kim,Jin Hee Kim,Hye Jung Cha,Tae Gyu Kim,Hae Jin Park,Sun Young Lee

European Journal of Surgical Oncology（2023）

引用 2|浏览31

暂无评分

摘要

SLNBx alone did not compromise oncological outcomes in patients with residual nodal disease after NAC. The omission of ALND might be a possible option for axillary management in patients treated with NAC and postoperative radiotherapy.

查看译文

关键词

Breast cancer,Neoadjuvant chemotherapy,Residual nodal disease,Sentinel lymph node biopsy,Axillary lymph node dissection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要